David T. Beranek

A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography

David T. Beranek, Constance C. Weis, David H. Swenson · Carcinogenesis · 1980 · 308 citations

Pharmacy, Biochemistry, Molecular Biology +12

Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis

Frederick A. Beland, David T. Beranek, Kenneth L. Dooley et al. · Environmental Health Perspectives · 1983 · 181 citations · Full text

Medicine, Pharmacology, Toxicology +16

Induction of mutations and sister-chromatid exchanges in Chinese hamster ovary cells by ethylating agents

Robert H. Heflich, David T. Beranek, Ralph L. Kodell et al. · Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis · 1982 · 102 citations

Life Sciences, Cell Biology, Genetics +8

Identification of N5-methyl-N5-formyl-2,5,6-triamino-4-hydroxypyrimidine as a major adduct in rat liver DNA after treatment with the carcinogens, N,N-dimethylnitrosamine or 1,2-dimethylhydrazine

David T. Beranek, Constance C. Weis, F E Evans et al. · Biochemical and Biophysical Research Communications · 1983 · 67 citations · Full text

Pharmacy, Molecular Biology, Toxicology +13

Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.

David T. Beranek, G. L. White, Robert H. Heflich et al. · Proceedings of the National Academy of Sciences · 1982 · 64 citations · Full text

Pharmacy, Microbiology, Toxicology +17